Compared to patients with normal vitamin D levels, patients with vitamin D deficiency were considered more than twice as likely to have diabetes, 29% more likely to have cardiomyopathy, and 40% more likely to have high blood pressure.
Vitamin D supplementation could significantly improve heart health in vitamin D deficient patients, according to a U.S. cohort study published in The American Journal of Cardiology.
Researchers at the University of Kansas tested serum vitamin D levels in 10,899 patients, 71% of whom were women and 70.3% of whom were vitamin D deficient.
Compared to patients with normal vitamin D levels, patients with vitamin D deficiency were considered more than twice as likely to have diabetes, 29% more likely to have cardiomyopathy, and 40% more likely to have high blood pressure. Furthermore, patients with vitamin D deficiency were more than three times as likely to die from all-cause death during the study.
Independent of cardio-protective drug use, patients who took vitamin D supplements saw better survival rates. These patients were 60% less likely to die from any cause during the study-a benefit deemed significant only in patients who initially tested as vitamin D deficient.
“Our study suggests a significant association of vitamin D supplement use and improved survival in deficient subjects, supporting the potential benefit of this intervention,” wrote the study’s lead researcher.
While the study supports gaining research on vitamin D and a potential benefit for heart health, some limitations were noted. Use of multivitamins was not considered as vitamin D supplementation and dose and duration of vitamin D supplementation were not analyzed.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.